Previous close | 95.68 |
Open | 96.39 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 96.39 - 96.51 |
52-week range | 84.64 - 109.00 |
Volume | |
Avg. volume | 42,819 |
Market cap | 197.269B |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 23.54 |
EPS (TTM) | 4.10 |
Earnings date | N/A |
Forward dividend & yield | 3.76 (3.90%) |
Ex-dividend date | 07 Mar 2024 |
1y target est | N/A |
Zacks.com users have recently been watching Novartis (NVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novartis (NVS) closed at $95.88 in the latest trading session, marking a +0.64% move from the prior day.
Mesoblast (MESO) gains as the FDA states that the available phase III data for lead candidate, remestemcel-L, is sufficient to support a regulatory filing for pediatric SR-aGVHD indication.